ANN HANHAM Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANN HANHAM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANN HANHAM. ANN HANHAM is Director in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and Director in SCYNEXIS INC ($SCYX) and Director in ENDOCYTE INC ($ECYT) and Director in IMMUNICON CORP ($IMMC).
Latest Insider Trading Transactions of ANN HANHAM
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ECYT, HTGM, IMMC, SCYX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 23 2020 | SCYX | SCYNEXIS INC | HANHAM ANN | Director | Option Exercise | A | 8.25 | 1,600 | 13,200 | 1,600 | |
Dec 23 2020 | SCYX | SCYNEXIS INC | HANHAM ANN | Director | Option Exercise | A | 7.33 | 1,600 | 11,728 | 1,600 | |
Dec 23 2020 | SCYX | SCYNEXIS INC | HANHAM ANN | Director | Buy | P | 6.25 | 3,200 | 20,000 | 3,622 | 422 to 3.6 K (+758.29 %) |
Aug 21 2020 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Option Exercise | A | 0.46 | 60,000 | 27,600 | 60,000 | |
Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Grant | A | 0.00 | 2,500 | 0 | 7,304 | 4.8 K to 7.3 K (+52.04 %) |
Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Grant | A | 0.00 | 2,500 | 0 | 7,304 | 4.8 K to 7.3 K (+52.04 %) |
Jun 20 2019 | SCYX | SCYNEXIS INC | HANHAM ANN | Director | Option Exercise | A | 1.29 | 45,000 | 58,050 | 45,000 | |
Jan 04 2019 | SCYX | SCYNEXIS INC | HANHAM ANN | Director | Option Exercise | A | 0.54 | 22,500 | 12,242 | 22,500 | |
Sep 12 2018 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Grant | A | 4.34 | 2,304 | 9,999 | 4,804 | 2.5 K to 4.8 K (+92.16 %) |
Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Option Exercise | A | 3.31 | 10,000 | 33,100 | 10,000 | |
Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Jan 04 2018 | SCYX | SCYNEXIS INC | HANHAM ANN | Director | Option Exercise | A | 2.28 | 19,989 | 45,575 | 19,989 | |
Aug 16 2017 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Option Exercise | A | 2.27 | 6,000 | 13,620 | 6,000 | |
May 05 2017 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Option Exercise | A | 2.27 | 19,500 | 44,265 | 19,500 | |
May 05 2017 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Grant | A | 0.00 | 3,300 | 0 | 7,800 | 4.5 K to 7.8 K (+73.33 %) |
Jan 05 2017 | SCYX | SCYNEXIS INC | HANHAM ANN | Director | Option Exercise | A | 3.40 | 14,499 | 49,297 | 14,499 | |
Aug 29 2016 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Option Exercise | A | 2.61 | 10,000 | 26,100 | 10,000 | |
Jun 06 2016 | SCYX | SCYNEXIS INC | HANHAM ANN | Director | Option Exercise | A | 3.98 | 8,800 | 35,024 | 8,800 | |
May 27 2016 | SCYX | SCYNEXIS INC | HANHAM ANN | Director | Buy | P | 3.64 | 4,225 | 15,379 | 4,225 | 0 to 4.2 K |
May 06 2016 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Option Exercise | A | 3.35 | 13,500 | 45,225 | 13,500 | |
May 06 2016 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Grant | A | 0.00 | 2,250 | 0 | 4,500 | 2.3 K to 4.5 K (+100.00 %) |
Jun 05 2015 | SCYX | SCYNEXIS INC | HANHAM ANN | Director | Option Exercise | A | 8.65 | 8,800 | 76,120 | 8,800 | |
May 18 2015 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Option Exercise | A | 6.02 | 13,500 | 81,270 | 13,500 | |
May 18 2015 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Grant | A | 0.00 | 2,250 | 0 | 2,250 | 0 to 2.3 K |
Apr 23 2004 | IMMC | IMMUNICON CORP | HANHAM ANN | Director | Option Exercise | C | 0.00 | 525,000 | 0 | 0 | |
Apr 23 2004 | IMMC | IMMUNICON CORP | HANHAM ANN | Director | Option Exercise | C | 0.00 | 1,225,000 | 0 | 0 | |
Apr 23 2004 | IMMC | IMMUNICON CORP | HANHAM ANN | Director | Buy | M | 0.00 | 350,000 | 0 | 350,000 | 0 to 350 K |
Apr 23 2004 | IMMC | IMMUNICON CORP | HANHAM ANN | Director | Buy | M | 0.00 | 816,667 | 0 | 816,667 | 0 to 816.7 K |
Page: 1